CJC-1295 + Ipamorelin BlendCertificate of Analysis

  • Tested by Janoshik Analytical
  • Report #101366
Janoshik AnalyticalCertificate of Analysis · PragueReport #101366

CJC-1295 + Ipamorelin Blend

Lot CP1026Aa01 · Quantitative content analysis (per vial)

Full report on Janoshik Analytical (opens in new tab)
CJC-1295 + Ipamorelin Blend vial
CJC-1295 + Ipamorelin Blend results reported by Janoshik Analytical
TestResultStatus
CJC‑1295 (mod GRF 1‑29)
  • 5.61 mg
Measured
Measured
Ipamorelin
  • 4.66 mg
Measured
Measured

Figures copied exactly from Janoshik Analytical's own report. Open it to check every line.

HPLC testing methodology

High-Performance Liquid Chromatography (HPLC) is the standard analytical technique used to verify peptide purity. Peptide labs typically run reverse-phase HPLC with UV detection. The chromatogram displays retention time on the x-axis and UV absorbance on the y-axis. The area under each peak corresponds to compound quantity. Purity is calculated as the target peak area divided by total peak area, expressed as a percentage. A purity of 98% or above is the usual research-grade threshold.

Storage & handling

Research peptides should be stored lyophilized (freeze-dried) at -20°C or below until ready for use. Avoid repeated freeze-thaw cycles. Upon reconstitution, store at 4°C and use within 30 days. Keep away from direct light and moisture. All handling should be performed under sterile research conditions by qualified personnel following applicable laboratory safety protocols.

Intended use

CJC-1295 + Ipamorelin Blend is supplied for laboratory research purposes only. Not intended for human or veterinary use, diagnostic procedures, or clinical applications.